Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study

Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study

Salvatrice Mancuso,1 Melania Carlisi,1 Nicola Serra,2,3 Mariasanta Napolitano,1 Simona Raso,3 Ugo Consoli,4 Roberto Palazzolo,5 Maria Rosa Lanza Cariccio,6 Sergio Siragusa1 1Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, Universit...

Full description

Bibliographic Details
Main Authors:	Mancuso S, Carlisi M, Serra N, Napolitano M, Raso S, Consoli U, Palazzolo R, Lanza Cariccio MR, Siragusa S
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-08-01
Series:	Journal of Blood Medicine
Subjects:	primary immune thrombocytopenia (itp) immuno-geriatrics tpo-receptor agonist itp treatment aging.
Online Access:	https://www.dovepress.com/clinical-phenotype-and-response-to-different-lines-of-therapy-in-elder-peer-reviewed-article-JBM

Similar Items

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia
by: A. A. Maschan, et al.
Published: (2022-11-01)

Thrombocytopenia induced by clopidogrel: a rare adverse effect
by: Catarina Távora, et al.
Published: (2023-10-01)

Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01)

ASH 2019 guidelines for immune thrombocytopenia: “Old wine in a new bottle with added spices”
by: Ravi M. Shah, et al.
Published: (2021-06-01)

Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
by: Lamya Garabet, et al.
Published: (2020-02-01)

First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
by: Sang Ngoc Nguyen, PhD, et al.
Published: (2021-10-01)

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
by: Simone Birocchi, et al.
Published: (2021-02-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
by: Rick Kapur, et al.
Published: (2020-04-01)

Partial splenic embolization for refractory thrombocytopenia
by: Irwin M. Best
Published: (2011-12-01)

Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)

Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
by: Dorela Lame, et al.
Published: (2024-03-01)

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options
by: Alina Mititelu, et al.
Published: (2024-02-01)

Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)

Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
by: Arthur Mageau, et al.
Published: (2023-12-01)

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
by: Martin Koch, et al.
Published: (2021-07-01)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
by: Tsykunova G, et al.
Published: (2022-03-01)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
by: Lambert MP
Published: (2016-06-01)

Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
by: Mahsa Matinkia, et al.
Published: (2021-11-01)

ORAL MANIFESTATIONS OF IMMUNE THROMBOCYTOPENIA IN CHILDREN
by: Vasile Eduard Roşu, et al.
Published: (2022-06-01)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)

Predictors of Remission in Severe Childhood Immune Thrombocytopenia
by: Chao-Neng Cheng, et al.
Published: (2023-01-01)

Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review
by: Iman Moustafa, et al.
Published: (2019-08-01)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
by: Emilie C. Collins, et al.
Published: (2021-10-01)

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01)

Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy
by: Giuseppe Palumbo, et al.
Published: (2023-12-01)

IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022-10-01)

Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia
by: Mihnea-Alexandru Găman, et al.
Published: (2017-03-01)

An unusual immune thrombocytopenia case associated with dietary supplements containing 3G (Green tea, Ginseng and Guarana)
by: Mehmet Zahid Kocak, et al.
Published: (2020-09-01)

Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
by: Rui-jie Sun, et al.
Published: (2019-03-01)

Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine
by: Lorenzo Cirasino, et al.
Published: (2020-05-01)

Novel scientific approaches and future research directions in understanding ITP
by: Sarah M. Hicks, et al.
Published: (2020-04-01)

Endothelial alterations in a canine model of immune thrombocytopenia
by: Dana N. LeVine, et al.
Published: (2019-01-01)

Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
by: Wobke E. M. van Dijk, et al.
Published: (2021-10-01)